Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Regeneron recently announced it would initiate a quarterly dividend of $0.88, a competitive amount for a company first ...

EDT Regeneron (REGN) down 3% after appeals court decision in Amgen (AMGN) patent fightLight Up your Portfolio with Spark:Easily identify ...

Regeneron Pharmaceuticals (REGN) appealed a decision of the United States District Court for the Northern District of West Virginia denying ...

Markets are tanking on tariff fears, inflationary concerns and now fears of recession. “Given this is so uncertain and that ...

Regeneron Pharmaceuticals Inc. (NASDAQ ... The company also announced its first-ever dividend and authorized another $3 ...

Regeneron is now a dividend-paying company. The stock has lagged the market over the last year, and that remains true after the post-earnings rise. Where to invest $1,000 right now? Our analyst ...

The figure also surpassed the Zacks Consensus Estimate of $44.96. Regeneron initiated a quarterly cash dividend program and declared a dividend of $0.88 per share. The dividend is payable on March ...

We recently published a list of What Did Jim Cramer Say About These 19 Stocks Recently? In this article, we are going to take ...

Yes, its dividend yield is not that great at the moment, but Regeneron's financial policy reminds me of AstraZeneca (AZN), which first seeks to strengthen its presence in fast-growing therapeutic ...

Regeneron initiated a quarterly dividend per share that looks somewhat attractive. Despite some recent issues, the biotech company's business remains solid. Regeneron's share repurchase program ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.